Maravai LifeSciences (MRVI) News Today $2.10 +0.09 (+4.23%) As of 10:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRVI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period SG Americas Securities LLC Acquires 662,861 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)SG Americas Securities LLC boosted its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 2,005.9% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 695,907 shares of the company's stock afteJune 16, 2025 | marketbeat.comBrokerages Set Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) PT at $6.64June 13, 2025 | americanbankingnews.comInvestors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors purchased 1,002 put options on the company. This represents an increase of approximately 1,791% compared to the typical volume of 53 put options.June 12, 2025 | marketbeat.comMaravai LifeSciences Appoints Bernd Brust To Succeed William Martin III As CEOJune 11, 2025 | nasdaq.comMaravai LifeSciences Appoints Bernd Brust as CEO, Succeeding Trey MartinJune 11, 2025 | nasdaq.comMaravai LifeSciences names Bernd Brust as new CEOJune 10, 2025 | investing.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by AnalystsMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) has been assigned an average rating of "Hold" from the twelve research firms that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, seven have assigned a hJune 10, 2025 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Down 4.8% - Here's What HappenedMaravai LifeSciences (NASDAQ:MRVI) Stock Price Down 4.8% - Here's What HappenedJune 9, 2025 | marketbeat.comMaravai LifeSciences Holdings Taps Bernd Brust as CEOJune 9, 2025 | marketwatch.comMaravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of DirectorsJune 9, 2025 | finance.yahoo.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP lowered its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 60.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 109,419 shares of the company'June 9, 2025 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Trading 8.5% Higher - What's Next?Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 8.5% - What's Next?June 6, 2025 | marketbeat.comTriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping TechnologyJune 3, 2025 | finance.yahoo.comTwo Sigma Advisers LP Sells 453,000 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Two Sigma Advisers LP lowered its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 67.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 216,500 shares of the company's stock after sellingJune 1, 2025 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Holdings Cut by Bank of America Corp DEBank of America Corp DE reduced its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 23.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 689,182 shares of the company's stock afteMay 31, 2025 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Up 6.1% - Here's WhyMaravai LifeSciences (NASDAQ:MRVI) Stock Price Up 6.1% - Still a Buy?May 30, 2025 | marketbeat.comMaravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI)Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the target of unusually large options trading on Wednesday. Stock traders acquired 1,002 put options on the stock. This is an increase of 1,791% compared to the typical volume of 53 put options.May 30, 2025 | marketbeat.comMackenzie Financial Corp Sells 180,696 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Mackenzie Financial Corp reduced its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,182,71May 27, 2025 | marketbeat.comQuantinno Capital Management LP Sells 269,103 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Quantinno Capital Management LP decreased its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 80.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 67,424 shaMay 27, 2025 | marketbeat.comMillennium Management LLC Has $10.40 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Millennium Management LLC lowered its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 55.9% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,907,261 shares of the company's stock after selling 2,418,051 shares duringMay 26, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 188,163 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 310.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 248,766 shares of the compaMay 26, 2025 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Purchased by Delta Investment Management LLCDelta Investment Management LLC raised its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 285.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 332,993 shaMay 22, 2025 | marketbeat.comCORRECTION – Maravai LifeSciences Releases 2024 Sustainability ReportMay 21, 2025 | globenewswire.comMaravai LifeSciencesReleases 2024 Sustainability ReportMay 21, 2025 | globenewswire.comMaravai LifeSciences Releases 2024 Sustainability ReportMay 21, 2025 | globenewswire.comDeutsche Bank AG Trims Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Deutsche Bank AG lowered its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 33.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,236,639 shares of the company's stock after sellMay 20, 2025 | marketbeat.comGotham Asset Management LLC Trims Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Gotham Asset Management LLC decreased its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 25.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 347,015 shares of the compMay 19, 2025 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Recommendation of "Hold" by BrokeragesShares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) have been given a consensus recommendation of "Hold" by the twelve analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have issued a hold rMay 18, 2025 | marketbeat.comLazard Asset Management LLC Buys 127,672 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Lazard Asset Management LLC raised its stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 9.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,447,714 shares of the company's stock after purchasing an additional 127,672 shares duriMay 17, 2025 | marketbeat.comStock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders purchased 1,002 put options on the stock. This represents an increase of approximately 1,791% compared to the typical volume of 53 put options.May 17, 2025 | marketbeat.comParkman Healthcare Partners LLC Invests $1.91 Million in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Parkman Healthcare Partners LLC purchased a new position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 350,000 shares of the company's stock, valued at approximately $1,9May 16, 2025 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Price Target Lowered to $2.00 at Robert W. BairdRobert W. Baird dropped their price objective on Maravai LifeSciences from $3.00 to $2.00 and set a "neutral" rating on the stock in a research note on Tuesday.May 15, 2025 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Releases Earnings Results, Misses Estimates By $0.08 EPSMaravai LifeSciences (NASDAQ:MRVI - Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.08). Maravai LifeSciences had a negative net margin of 81.13% and a negative return on equity of 6.61%.May 14, 2025 | marketbeat.comMaravai LifeSciences Holdings Inc (MRVI) Q1 2025 Earnings Call Highlights: Navigating Growth ...May 13, 2025 | finance.yahoo.comDimensional Fund Advisors LP Grows Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Dimensional Fund Advisors LP boosted its stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 20.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,311,700 shares of the company's stock aMay 13, 2025 | marketbeat.comMaravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comMaravai LifeSciences Holdings, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 13, 2025 | seekingalpha.comMaravai Lifesciences Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comMaravai LifeSciences Holdings Q1 2025 Earnings PreviewMay 11, 2025 | msn.comInsights Ahead: Maravai LifeSciences's Quarterly EarningsMay 10, 2025 | benzinga.comMaravai LifeSciences (NASDAQ:MRVI) Trading 4.6% Higher - Time to Buy?Maravai LifeSciences (NASDAQ:MRVI) Trading 4.6% Higher - Should You Buy?May 7, 2025 | marketbeat.comMaravai LifeSciences (MRVI) to Release Earnings on MondayMaravai LifeSciences (NASDAQ:MRVI) will be releasing its Q1 2025 earnings after the market closes on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-maravai-lifesciences-holdings-inc-stock/)May 7, 2025 | marketbeat.comAlyeska Investment Group L.P. Buys 3,161,072 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Alyeska Investment Group L.P. increased its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 145.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,329,420 shares of the company'sMay 7, 2025 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Position Lifted by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC raised its stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 1,960.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 533,643 shares of the company's stock after purchasing an additional 507,743 shares dMay 7, 2025 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Bought by Voya Investment Management LLCVoya Investment Management LLC lifted its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 337.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 346,723 shares of the company's stocMay 6, 2025 | marketbeat.comMRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 5, 2025 | globenewswire.comInvestors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact Levi & Korsinsky about pending Class Action - MRVIMay 5, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVIMay 5, 2025 | globenewswire.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesMay 5, 2025 | tmcnet.comMRVI DEADLINE TODAY: Maravai LifeSciences (MRVI) Investors Alerted to Today's Lead Plaintiff Deadline in Securities Class ActionMay 5, 2025 | globenewswire.com Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address MRVI Media Mentions By Week MRVI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRVI News Sentiment▼0.460.68▲Average Medical News Sentiment MRVI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRVI Articles This Week▼111▲MRVI Articles Average Week Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BHC News ARWR News DNLI News TWST News VCEL News KNSA News AGIO News SRPT News RXRX News APGE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRVI) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maravai LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
